MedTrace Logo

Sinupret Extract Coated Tablets in Chronic Rhinosinusitis

NCT02746042 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 572

Last updated 2018-02-28

No results posted yet for this study

Summary

To assess the efficacy of the herbal medicinal product Sinupret extract versus placebo in the treatment of chronic rhinosinusitis (CRS) in adults.

Conditions

  • Chronic Rhinosinusitis

Interventions

DRUG

Sinupret extract coated tablets

1 coated tablet 3 times a day for 16-weeks (1-1-1)

DRUG

Placebo coated tablets

1 coated tablet 3 times a day for 16-weeks (1-1-1)

Sponsors & Collaborators

  • Bionorica SE

    lead INDUSTRY

Principal Investigators

  • Jürgen Palm, Dr. · Praxis Dr. Jürgen Palm, 90552 Röthenbach/Pegnitz, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-28
Primary Completion
2017-07-26
Completion
2017-08-23

Countries

  • Germany
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02746042 on ClinicalTrials.gov